Е.П. Павликова

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• Qualitative and Quantitative Assessment of Pharmacotherapy in a Medical Organization: A Pilot Study2026
• Methods for assessing the quality of pharmacotherapy as tools for improving the effectiveness and safety of treatment interventions2025
• Cardiac manifestations in myotonic dystrophy type 12024
• Cognitive and emotional disturbances in adult patients with myotonic dystrophy type 12024
• Sleep Disorders and Fatigue in Patients with Different Forms of Myotonic Dystrophy Type 12024
• Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study2021
• AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial2020 · аннотациясвернуть

  In May 2020 the Russian Ministry of Health granted fast-track marketing authorization to RNA polymerase inhibitor AVIFAVIR (favipiravir) for the treatment of COVID-19 patients. In the pilot stage of Phase II/III…

• Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)2020 · аннотациясвернуть

  Introduction Coronavirus pneumonia not only severely affects the lung tissue but is also associated with systemic autoimmune inflammation, rapid overactivation of cytokines and chemokines known as "cytokine storm", and…